Shareholder Information

Key Shareholder Information

Corporate Presentation

An overview of the most recent information about MDxHealth can be found in the company’s periodic corporate presentation slides.  Click here

Corporate Governance Charter

MDxHealth attaches great value to corporate governance practices.
On September 7, 2011, our board of directors approved the current version of MDxHealth’s Corporate Governance Charter. The Charter has been drafted in accordance with the principles and the provisions of the Belgian Corporate Governance Code 2009 issued on March 12, 2009 by the Corporate Governance Committee.

The full text of MDxHealth’s Corporate Governance Charter can be downloaded here.

Code of Ethics

The full text of MDxHealth's Code of Ethics can be downloaded here.

Dealing Code

As a listed company, MDxHealth must comply with rules governing insider trading. The company's dealing code can be found here.

Articles of Association

The Articles of Association are periodically updated. The latest version (March 26, 2018) can be found here:

Share capital history

The history of the share capital issuance since the inception of the company can be found here:

Transparency Declarations of the largest shareholders

The table below provides an overview of the shareholders that filed a notifcation with MDxHealth SA pursuant to applicable transparency disclosure rules.  Although the applicable transparency disclosure rules require that a disclosure must be made by each person passing or falling under one of the relevant thresholds, it is possible that the information below in relation to a shareholder is no longer up-to-date.  The percentages of voting rights mentioned in the table have been calculated on the basis of the currently outstanding shares.

NUMBER OF SHARES 7,668,350 7,184,510 14,852,860 59,939,289
% OF OUTSTANDING SHARES 12.79% 11.99% 24.78% 100%
SITUATION AS OF March 22, 2018 March 22, 2018    

*Based on information provided on a voluntary basis following the capital increase on March 22, 2018

Ownership percentages are based on the latest number of outstanding shares, thus such percentages may be different than those reported in transparency declarations.

Each natural or legal person acquiring or transferring MDxHealth’s shares is required to notify MDxHealth and the Financial Services and Markets Authority (FSMA) each time their shareholding crosses a threshold of three percent (3%) of the total number of outstanding shares (the denominator). Such notification is also required each time, as a result of an acquisition or transfer a threshold of five percent (5%) and a multiple of five percent (5%) is crossed. Complete information regarding this requirement is found in Article 14 of MDxHealth’s articles of association.

The transparency notifications should be reported within 5 business days of crossing the threshold by following the procedures outlined on the FSMA website found here.

A copy of the transparency notification should also be emailed and faxed to the company, to the attention of: Jean-Marc Roelandt, Chief Financial Officer, at and fax +32 4 364 20 71.

Annual Shareholders' Meetings

The annual general shareholders’ meeting is held at the registered office or at the place determined in the notice convening the shareholders’ meeting. The meeting is held every year on the last Thursday of May at 10 a.m. The notice and agenda, as well as a model of power of attorney are made available here at least 30 calendar days prior to the annual shareholders' meeting.

Next Extraordinary Shareholder's Meeting Material

Notice/invitation/agenda for the Shareholders' meetings

Proxy form for the Annual Shareholders' meetings

Attendance form

Explanatory Note

Board Reports

Auditor's Report

Recent Shareholder meetings

Paying Agent

The financial service for the shares of the company is provided in Belgium by ING. Shareholders should inform themselves about the costs that other financial intermediaries may charge in connection with paying agency services.

Rapport spécial du conseil d'administration, Article 596, Nov. 2016

Rapport du conseil d'administration, article 604, 26 avril 2016

Rapport du conseil d'administration, article 604, 26 avril 2016

Special Reports of the Board and Auditor